| Product Code: ETC9973852 | Publication Date: Sep 2024 | Updated Date: Aug 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market - Industry Life Cycle |
3.4 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market - Porter's Five Forces |
3.5 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume Share, By Test Type, 2022 & 2032F |
3.6 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for rapid and accurate diagnostic testing at point of care settings |
4.2.2 Technological advancements leading to the development of innovative point of care diagnostic devices |
4.2.3 Rising prevalence of chronic diseases driving the need for quick diagnostic solutions |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of point of care diagnostic devices |
4.3.2 Limited reimbursement policies for point of care testing impacting adoption rates |
4.3.3 High cost associated with point of care diagnostic devices hindering market growth |
5 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Trends |
6 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market, By Types |
6.1 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Test Type, 2022-2032F |
6.1.3 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Clinical Chemistry, 2022-2032F |
6.1.4 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Immunodiagnostics, 2022-2032F |
6.2 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Infectious Diseases, 2022-2032F |
6.2.3 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Oncology, 2022-2032F |
6.2.4 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Endocrinology, 2022-2032F |
6.2.5 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Autoimmune Disorders, 2022-2032F |
6.2.6 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Basic Metabolite Panel, 2022-2032F |
6.2.7 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Others, 2022-2032F |
6.3 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.3 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Clinical Laboratories, 2022-2032F |
6.3.4 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Diagnostic Centers, 2022-2032F |
6.3.5 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Academic and Research Institutes, 2022-2032F |
6.3.6 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenues & Volume, By Others, 2022-2032F |
7 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Import-Export Trade Statistics |
7.1 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Export to Major Countries |
7.2 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Imports from Major Countries |
8 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Key Performance Indicators |
8.1 Average turnaround time for point of care diagnostic tests |
8.2 Adoption rate of point of care diagnostic devices in healthcare facilities |
8.3 Rate of accuracy and reliability of point of care diagnostic results |
8.4 Utilization rate of point of care diagnostic devices in different clinical settings |
8.5 Frequency of new product launches and technological innovations in the point of care diagnostic market |
9 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market - Opportunity Assessment |
9.1 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Opportunity Assessment, By Test Type, 2022 & 2032F |
9.2 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Opportunity Assessment, By End User, 2022 & 2032F |
10 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market - Competitive Landscape |
10.1 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here